Industrialization trial of a biosensor technology

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

A biosensing system is commercialized based on a concept of physiological balance for healthcare. The addition of low-cost biochemical sensors to the sensing system would help with scientific prescriptions based on contemporary medicine. As a candidate for a low-cost and robust chemical sensor platform, the ion-sensitive field-effect transistor (ISFET) has long been examined. After reviewing past ISFET research, our two approaches for new business trials are discussed. One approach is based on the progressiveness of technology that relies on a public finance with existing big companies. Another approach is a lean startup based on a customer development model for entrepreneurs.

Original languageEnglish
Title of host publicationContemporary Issues and Case Studies in Electrochemical Innovation 2
PublisherElectrochemical Society Inc.
Pages1-9
Number of pages9
Volume75
Edition39
ISBN (Electronic)9781607685395
DOIs
Publication statusPublished - 2016 Jan 1
EventSymposium on Contemporary Issues and Case Studies in Electrochemical Innovation 2 - PRiME 2016/230th ECS Meeting - Honolulu, United States
Duration: 2016 Oct 22016 Oct 7

Other

OtherSymposium on Contemporary Issues and Case Studies in Electrochemical Innovation 2 - PRiME 2016/230th ECS Meeting
CountryUnited States
CityHonolulu
Period16/10/216/10/7

    Fingerprint

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Ohashi, K., & Osaka, T. (2016). Industrialization trial of a biosensor technology. In Contemporary Issues and Case Studies in Electrochemical Innovation 2 (39 ed., Vol. 75, pp. 1-9). Electrochemical Society Inc.. https://doi.org/10.1149/07539.0001ecst